Form 8-K CANCER GENETICS, INC For: May 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Cancer Genetics (CGIX) Tops Q1 EPS by 4c
May 10, 2016 4:14 PM EDTCancer Genetics (NASDAQ: CGIX) reported Q1 EPS of ($0.39), $0.04 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $6.95 million.
For earnings history and earnings-related data on Cancer Genetics (CGIX) click here.
... More